Table 3.
Characteristics of fasting1 versus non-fasting participants by sex, the HUNT 2 study
| Men | Women | |||||
| Fasting1 | Non fasting | Fasting1 | Non fasting | |||
| N (%) | 5101 (17.0%) |
24,914 (83.0%) |
5105 (15.2%) |
28,480 (84.8%) |
||
| Categorical measures, % (95% CI) | Odds ratio | Odds ratio | ||||
| IDF-proxy for metabolic syndrome2 | 13.8 (12.8–14.7) |
14.4 (14.0–14.9) |
1.05 (0.97–1.15) |
14.8 (13.9–15.8) |
13.8 (13.4–14.2) |
0.92 (0.85–1.00) |
| ATP-proxy for metabolic syndrome3 | 5.8 (5.2–6.5) |
5.8 (5.5–6.1) |
1.00 (0.88–1.14) |
9.8 (8.9–10.6) |
9.0 (8.7–9.4) |
0.92 (0.83–1.02) |
| Type 2 diabetes | 1.6 (1.2–1.9) |
1.9 (1.7–2.0) |
1.18 (0.93–1.49) |
2.0 (1.6–2.4) |
1.6 (1.5–1.8) |
0.81 (0.65–1.01) |
| Antihypertensive medication | 10.3 (9.5–11.1) |
10.3 (9.9–10.6) |
1.00 (0.90–1.10) |
13.1 (12.2–14.0) |
11.6 (11.2–12.0) |
0.87* (0.80–0.96) |
| Continuous measures, means (95% CI) | Mean z-score diff. | Mean z-score diff. | ||||
| Age, y | 48.4 (48.0–48.9) |
50.0 (49.8–50.2) |
0.093* | 49.4 (48.9–49.8) |
50.2 (50.0–50.4) |
0.048* |
| Systolic blood pressure, mm Hg | 140.4 (139.8–140.9) |
140.0 (139.7–140.2) |
-0.022 | 137.3 (136.6–137.9) |
135.8 (135.5–136.1) |
-0.062* |
| Diastolic blood pressure, mm Hg | 83.4 (83.0–83.7) |
81.7 (81.6–81.9) |
-0.138* | 80.0 (79.6–80.3) |
78.7 (78.6–78.9) |
-0.101* |
| Waist circumference, cm | 92.2 (91.9–92.5) |
91.9 (91.8–92.0) |
-0.028 | 82.0 (81.7–82.4) |
81.5 (81.4–81.6) |
-0.050* |
| HDL cholesterol, mmol/L | 1.26 (1.25–1.27) |
1.24 (1.23–1.24) |
-0.063* | 1.50 (1.49–1.52) |
1.49 (1.49–1.50) |
-0.029 |
| Triglycerides, mmol/L | 1.73 (1.70–1.76) |
2.02 (2.01–2.04) |
0.240* | 1.44 (1.42–1.47) |
1.59 (1.58–1.60) |
0.153* |
| Glucose, mmol/L | 5.30 (5.27–5.33) |
5.60 (5.58–5.62) |
0.185* | 5.20 (5.17–5.23) |
5.41 (5.40–5.43) |
0.150* |
HUNT, the Nord-Trøndelag Health study; CI, confidence interval; IDF, the International Diabetes Federation; ATP, the National Cholesterol Education
Program-Adult Treatment Panel III; HDL, high-density lipoprotein.
*P < 0.05.
1Four to nine hours or more since the last meal.
2IDF-proxy for metabolic syndrome defined as IDF-central obesity plus any two of three components (low HDL cholesterol, high blood pressure or treatment for previously diagnosed hypertension, or previously diagnosed type 2 diabetes).
3ATP-proxy for metabolic syndrome defined as any three of four components (ATP III-defined central obesity, low HDL cholesterol, high blood pressure or treatment for previously diagnosed hypertension, or previously diagnosed type 2 diabetes).